Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour

被引:10
作者
Gaudreault, Mathieu [1 ,2 ]
Chang, David [2 ,3 ]
Hardcastle, Nicholas [1 ,2 ,4 ]
Jackson, Price [1 ,2 ]
Kron, Tomas [1 ,2 ,4 ]
Hofman, Michael S. [2 ,5 ,6 ]
Siva, Shankar [2 ,3 ]
机构
[1] Peter MacCallum Canc Ctr, Dept Phys Sci, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3000, Australia
[3] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic 3000, Australia
[4] Univ Wollongong, Ctr Med Radiat Phys, Wollongong, NSW 2522, Australia
[5] Peter MacCallum Canc Ctr, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic 3000, Australia
[6] Peter MacCallum Canc Ctr, Prostate Canc Theranost & Imaging Ctr Excellence, Melbourne, Vic 3000, Australia
关键词
BgRT; PSMA; DIL; Prostate; BTZ; PRIMARY PROSTATE-CANCER; RADIATION-THERAPY; MULTIPARAMETRIC MRI; LOCAL RECURRENCE; GA-68-PSMA; TOXICITY; EFFICACY;
D O I
10.1016/j.ctro.2022.05.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Biology-guided radiotherapy (BgRT) delivers dose to tumours triggered from positron emission tomography (PET) detection. Prostate specific membrane antigen (PSMA) PET uptake is abundant in the dominant intraprostatic lesion (DIL). This study investigates the feasibility of BgRT to PSMA-avid subvolume in the prostate region. Methods: Patients enrolled in the prospective randomized trial ProPSMA at our institution were included (ID: ANZCTR12617000005358). Gross tumour volumes (GTVs) were delineated on the PET component of a PET/CT scan from a standardized uptake value (SUV) threshold technique. Suitability for BgRT requires a strong signalto-background ratio with a surrounding tissue free of significant PSMA uptake. The signal-to-background ratio was quantified from the calculation of the normalized SUV (nSUV), defined as the ratio between SUVmax within the GTV and SUVmean inside a 3D margin expansion of the GTV. The PSMA distribution surrounding the tumour was quantified as a function of the distance from the GTV. Results: In this cohort of 84 patients, 83 primary tumours were included. Prostate volume ranged from 19 cm(3) to 148 cm(3) (median = 52 cm(3); IQR = 39 cm(3) - 63 cm(3)). SUVmax inside the prostate was between 2 and 125 (median = 19; IQR = 11 - 30). More than 50% of GTVs generated with threshold between 25%SUVmax (median volume = 10.0 cm(3); IQR = 4.5 cm(3) - 20.0 cm(3)) and 50%SUVmax (median volume = 1.9 cm(3); IQR = 1.1 cm 3 - 3.8 cm(3)) were suitable for BgRT by using nSUV >= 3 and a margin expansion of 5 mm. Conclusions: It is feasible to identify GTVs suitable for BgRT in the prostate. These GTVs are characterized by a strong signal-to-background ratio and a surrounding tissue free of PSMA uptake.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 50 条
  • [1] Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study
    Ahmed, Hashim U.
    Hindley, Richard G.
    Dickinson, Louise
    Freeman, Alex
    Kirkham, Alex P.
    Sahu, Mahua
    Scott, Rebecca
    Allen, Clare
    Van der Meulen, Jan
    Emberton, Mark
    [J]. LANCET ONCOLOGY, 2012, 13 (06) : 622 - 632
  • [2] Accuracy of Dose Calibrators for 68Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial Assessment
    Bailey, Dale L.
    Hofman, Michael S.
    Forwood, Nicholas J.
    O'Keefe, Graeme J.
    Scott, Andrew M.
    van Wyngaardt, Winifred M.
    Howe, Bonnie
    Kovacev, Olga
    Francis, Roslyn J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 636 - 638
  • [3] Boosting imaging defined dominant prostatic tumors: A systematic review
    Bauman, Glenn
    Haider, Masoom
    Van der Heide, Uulke A.
    Menard, Cynthia
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 274 - 281
  • [4] [68Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - Implications for focal radiotherapy planning in primary prostate cancer
    Bettermann, Alisa S.
    Zamboglou, Constantinos
    Kiefer, Selina
    Jilg, Cordula A.
    Spohn, Simon
    Kranz-Rudolph, Jasmin
    Fassbender, Thomas F.
    Bronsert, Peter
    Nicolay, Nils H.
    Gratzke, Christian
    Bock, Michael
    Ruf, Juri
    Benndorf, Matthias
    Grosu, Anca L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 214 - 219
  • [5] Molecular Imaging of Urogenital Diseases
    Cho, Steve Y.
    Szabo, Zsolt
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2014, 44 (02) : 93 - 109
  • [6] Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
    Demirci, Emre
    Kabasakal, Levent
    Sahin, Onur E.
    Akgun, Elife
    Gultekin, Mehmet Hamza
    Doganca, Tunkut
    Tuna, Mustafa B.
    Obek, Can
    Kilic, Mert
    Esen, Tarik
    Kural, Ali R.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (01) : 86 - 91
  • [7] Optimal68Ga-PSMA and18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer
    Draulans, Cedric
    De Roover, Robin
    van der Heide, Uulke A.
    Kerkmeijer, Linda
    Smeenk, Robert J.
    Pos, Floris
    Vogel, Wouter V.
    Nagarajah, James
    Janssen, Marcel
    Isebaert, Sofie
    Maes, Frederik
    Mai, Cindy
    Oyen, Raymond
    Joniau, Steven
    Kunze-Busch, Martina
    Goffin, Karolien
    Haustermans, Karin
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (04) : 1211 - 1218
  • [8] Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
    Eiber, Matthias
    Fendler, Wolfgang P.
    Rowe, Steven P.
    Calais, Jeremie
    Hofman, Michael S.
    Maurer, Tobias
    Schwarzenboeck, Sarah M.
    Kratowchil, Clemens
    Herrmann, Ken
    Giesel, Frederik L.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 : 67S - 76S
  • [9] Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
    Eiber, Matthias
    Weirich, Gregor
    Holzapfel, Konstantin
    Souvatzoglou, Michael
    Haller, Bernhard
    Rauscher, Isabel
    Beer, Ambros J.
    Wester, Hans-Juergen
    Gschwend, Juergen
    Schwaiger, Markus
    Maurer, Tobias
    [J]. EUROPEAN UROLOGY, 2016, 70 (05) : 829 - 836
  • [10] Detection Efficacy of Hybrid 68Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria
    Einspieler, Ingo
    Rauscher, Isabel
    Duewel, Charlotte
    Kroenke, Markus
    Rischpler, Christoph
    Habl, Gregor
    Dewes, Sabrina
    Ott, Armin
    Wester, Hans-Juergen
    Schwaiger, Markus
    Maurer, Tobias
    Eiber, Matthias
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) : 1081 - 1087